由于红细胞增多可能需要降低剂量或停止治疗，故应在开始治疗前、初始治疗后的3 ~6个月以及随后的每年检测红细胞比积。
Because polycythemia may require dose reductions or discontinuation of therapy, hematocrit should be obtained at baseline, 3 to 6 months after initiation of therapy, and annually thereafter.
采用自清洗旋转式黏度计检测高血压患者全血黏度(高、低切)、血浆比黏度、红细胞压积、全血还原黏度和K值方程。
The whole blood viscosity (high and low shearing), plasma viscosity, haematocrit, whole blood reduced viscosity and K value equation were detected with the auto cleaning rotating viscometer.
红细胞压积(HCT,PCV)测量样品中红细胞的百分比，侦察如贫血和脱水这些状态。
Hematocrit (HCT, PCV) measures the percentage of red blood cells in the sample to detect conditions such as anemia and dehydration.
因此，胸腔内血容量指数比中心静脉压和红细胞压积更适合应用在坏死性胰腺炎患者的容量管理。
Therefore, intrathoracic blood volume index appears to be more appropriate for volume management in necrotizing pancreatitis than central venous pressure or hematocrit.
因此，胸腔内血容量指数比中心静脉压和红细胞压积更适合应用在坏死性胰腺炎患者的容量管理。
Therefore, intrathoracic blood volume index appears to be more appropriate for volume management in necrotizing pancreatitis than central venous pressure or hematocrit.
应用推荐